Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System

Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper sho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of clinical endocrinology and metabolism 2005-02, Vol.90 (2), p.992-1000
Hauptverfasser: Carrillo-Vico, Antonio, Lardone, Patricia J., Fernández-Santos, José M., Martín-Lacave, Inés, Calvo, Juan R., Karasek, Michal, Guerrero, Juan M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1000
container_issue 2
container_start_page 992
container_title The journal of clinical endocrinology and metabolism
container_volume 90
creator Carrillo-Vico, Antonio
Lardone, Patricia J.
Fernández-Santos, José M.
Martín-Lacave, Inés
Calvo, Juan R.
Karasek, Michal
Guerrero, Juan M.
description Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.
doi_str_mv 10.1210/jc.2004-1429
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67410847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67410847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</originalsourceid><addsrcrecordid>eNptkNGL1DAQxoMo3rr65rP0RZ_MXZImafsox-ktrAiegm8hzU7d7qXJmrS31L_eWXfhEAwkwzfzy2TyEfKas0suOLvauUvBmKRciuYJWfBGKlrxpnpKFowJTptK_LggL3LeMcalVOVzcsGV0gLVghxup8GGYj0P-2108wj0bg7jFnL_GzbFZ_B2jKEPxSoXq_AQ_QNmUSJRfIWfE5b7GIrY_c2swgjJw3TfByqu_lFIO9iPMRV3cx5heEmeddZneHWOS_L9482361u6_vJpdf1hTZ2UuqINcK4400pjrKBl1lUtK8tOdnWtWy0kF13XNDWzUGtWa8cF1LJuAStSi3JJ3p367lP8NUEezdBnB97bAHHKRleSs1pWCL4_gS7FnBN0Zp_6wabZcGaORpudM0ejzdFoxN-c-07tAJtH-OwsAm_PgM3O-i7Z4Pr8yGklKoU_WRJ54g7Ro1_53k8HSGYL1o9bw3ChDzXFlxXDg1Hc6jhueboGYRNd6gPsE-RsdnFKAQ39_9R_AEPZphU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67410847</pqid></control><display><type>article</type><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</creator><creatorcontrib>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</creatorcontrib><description>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2004-1429</identifier><identifier>PMID: 15562014</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adult ; Biological and medical sciences ; Cells, Cultured ; Endocrinopathies ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation - immunology ; Humans ; Interleukin-2 - genetics ; Interleukin-2 - physiology ; Lymphocytes - drug effects ; Lymphocytes - immunology ; Medical sciences ; Melatonin - biosynthesis ; Middle Aged ; Receptors, Interleukin-2 - genetics ; Receptors, Interleukin-2 - physiology ; Receptors, Melatonin - antagonists &amp; inhibitors ; Receptors, Melatonin - physiology ; Tryptamines - pharmacology ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.992-1000</ispartof><rights>Copyright © 2005 by The Endocrine Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</citedby><cites>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16527503$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15562014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carrillo-Vico, Antonio</creatorcontrib><creatorcontrib>Lardone, Patricia J.</creatorcontrib><creatorcontrib>Fernández-Santos, José M.</creatorcontrib><creatorcontrib>Martín-Lacave, Inés</creatorcontrib><creatorcontrib>Calvo, Juan R.</creatorcontrib><creatorcontrib>Karasek, Michal</creatorcontrib><creatorcontrib>Guerrero, Juan M.</creatorcontrib><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Endocrinopathies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation - immunology</subject><subject>Humans</subject><subject>Interleukin-2 - genetics</subject><subject>Interleukin-2 - physiology</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - immunology</subject><subject>Medical sciences</subject><subject>Melatonin - biosynthesis</subject><subject>Middle Aged</subject><subject>Receptors, Interleukin-2 - genetics</subject><subject>Receptors, Interleukin-2 - physiology</subject><subject>Receptors, Melatonin - antagonists &amp; inhibitors</subject><subject>Receptors, Melatonin - physiology</subject><subject>Tryptamines - pharmacology</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkNGL1DAQxoMo3rr65rP0RZ_MXZImafsox-ktrAiegm8hzU7d7qXJmrS31L_eWXfhEAwkwzfzy2TyEfKas0suOLvauUvBmKRciuYJWfBGKlrxpnpKFowJTptK_LggL3LeMcalVOVzcsGV0gLVghxup8GGYj0P-2108wj0bg7jFnL_GzbFZ_B2jKEPxSoXq_AQ_QNmUSJRfIWfE5b7GIrY_c2swgjJw3TfByqu_lFIO9iPMRV3cx5heEmeddZneHWOS_L9482361u6_vJpdf1hTZ2UuqINcK4400pjrKBl1lUtK8tOdnWtWy0kF13XNDWzUGtWa8cF1LJuAStSi3JJ3p367lP8NUEezdBnB97bAHHKRleSs1pWCL4_gS7FnBN0Zp_6wabZcGaORpudM0ejzdFoxN-c-07tAJtH-OwsAm_PgM3O-i7Z4Pr8yGklKoU_WRJ54g7Ro1_53k8HSGYL1o9bw3ChDzXFlxXDg1Hc6jhueboGYRNd6gPsE-RsdnFKAQ39_9R_AEPZphU</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Carrillo-Vico, Antonio</creator><creator>Lardone, Patricia J.</creator><creator>Fernández-Santos, José M.</creator><creator>Martín-Lacave, Inés</creator><creator>Calvo, Juan R.</creator><creator>Karasek, Michal</creator><creator>Guerrero, Juan M.</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><author>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Endocrinopathies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation - immunology</topic><topic>Humans</topic><topic>Interleukin-2 - genetics</topic><topic>Interleukin-2 - physiology</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - immunology</topic><topic>Medical sciences</topic><topic>Melatonin - biosynthesis</topic><topic>Middle Aged</topic><topic>Receptors, Interleukin-2 - genetics</topic><topic>Receptors, Interleukin-2 - physiology</topic><topic>Receptors, Melatonin - antagonists &amp; inhibitors</topic><topic>Receptors, Melatonin - physiology</topic><topic>Tryptamines - pharmacology</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carrillo-Vico, Antonio</creatorcontrib><creatorcontrib>Lardone, Patricia J.</creatorcontrib><creatorcontrib>Fernández-Santos, José M.</creatorcontrib><creatorcontrib>Martín-Lacave, Inés</creatorcontrib><creatorcontrib>Calvo, Juan R.</creatorcontrib><creatorcontrib>Karasek, Michal</creatorcontrib><creatorcontrib>Guerrero, Juan M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carrillo-Vico, Antonio</au><au>Lardone, Patricia J.</au><au>Fernández-Santos, José M.</au><au>Martín-Lacave, Inés</au><au>Calvo, Juan R.</au><au>Karasek, Michal</au><au>Guerrero, Juan M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2005-02</date><risdate>2005</risdate><volume>90</volume><issue>2</issue><spage>992</spage><epage>1000</epage><pages>992-1000</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>15562014</pmid><doi>10.1210/jc.2004-1429</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-972X
ispartof The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.992-1000
issn 0021-972X
1945-7197
language eng
recordid cdi_proquest_miscellaneous_67410847
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals
subjects Adult
Biological and medical sciences
Cells, Cultured
Endocrinopathies
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation - immunology
Humans
Interleukin-2 - genetics
Interleukin-2 - physiology
Lymphocytes - drug effects
Lymphocytes - immunology
Medical sciences
Melatonin - biosynthesis
Middle Aged
Receptors, Interleukin-2 - genetics
Receptors, Interleukin-2 - physiology
Receptors, Melatonin - antagonists & inhibitors
Receptors, Melatonin - physiology
Tryptamines - pharmacology
Vertebrates: endocrinology
title Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T15%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Lymphocyte-Synthesized%20Melatonin%20Is%20Involved%20in%20the%20Regulation%20of%20the%20Interleukin-2/Interleukin-2%20Receptor%20System&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Carrillo-Vico,%20Antonio&rft.date=2005-02&rft.volume=90&rft.issue=2&rft.spage=992&rft.epage=1000&rft.pages=992-1000&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2004-1429&rft_dat=%3Cproquest_cross%3E67410847%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67410847&rft_id=info:pmid/15562014&rfr_iscdi=true